Pelbreton C Balfour1, Jorge A Gonzalez2, Peter W Shaw3, Margarita P Caminero4, Eric M Holland5, Jack W Melson1, Michael Sobczak1, Valerie Izarnotegui1, Denny D Watson1,6, George A Beller1,6, Jamieson M Bourque7,8. 1. Cardiovascular Division, Department of Medicine, Cardiovascular Imaging Center, University of Virginia Health System, 1215 Lee Street, Box 800662, Charlottesville, VA, 22908, USA. 2. Division of Cardiovascular Disease, Scripps Clinic, La Jolla, CA, USA. 3. Berkshire Medical Center, Pittsfield, MA, USA. 4. Cardiac and Vascular Institute, Memorial Healthcare System, Hollywood, FL, USA. 5. University of North Carolina, Chapel Hill, NC, USA. 6. Departments of Radiology, University of Virginia Health System, Charlottesville, VA, USA. 7. Cardiovascular Division, Department of Medicine, Cardiovascular Imaging Center, University of Virginia Health System, 1215 Lee Street, Box 800662, Charlottesville, VA, 22908, USA. jamieson2@gmail.com. 8. Departments of Radiology, University of Virginia Health System, Charlottesville, VA, USA. jamieson2@gmail.com.
Abstract
BACKGROUND: Exercise stress electrocardiography (ECG) alone is underutilized in part due to poor diagnostic accuracy. High-frequency QRS analysis (HF-QRS) is a novel tool to supplement ST evaluation during stress ECG. We compared the diagnostic accuracy and net reclassification of HF-QRS analysis compared with ST evaluation for substantial myocardial ischemia by exercise SPECT myocardial perfusion imaging (MPI). METHODS AND RESULTS: Exercise SPECT MPI was performed in 257 consecutive eligible patients (mean age 59 ± 12, 67% male). An ischemic HF-QRS pattern was defined as a ≥ 1 µV absolute reduction and a ≥ 50% relative reduction of the root-mean-square of the 150-250 Hz band signal in ≥ 3 leads. Left ventricular ischemia of ≥ 10% on SPECT MPI was the diagnostic standard for substantial myocardial ischemia. HF-QRS analysis demonstrated incremental diagnostic value to ST evaluation plus clinical risk factors (AUC 0.804 vs 0.749, P < .0001). A HF-QRS + ST -analysis strategy identified 92.3% of subjects with substantial ischemia and no abnormality in 59.9% of the cohort. No cardiac events occurred in patients without substantial ischemia identified by HF-QRS analysis. CONCLUSIONS: In this prospective analysis, exercise stress ECG with HF-QRS analysis identified any and substantial ischemia with high diagnostic accuracy and may allow more than half of referred patients to safely avoid imaging.
BACKGROUND: Exercise stress electrocardiography (ECG) alone is underutilized in part due to poor diagnostic accuracy. High-frequency QRS analysis (HF-QRS) is a novel tool to supplement ST evaluation during stress ECG. We compared the diagnostic accuracy and net reclassification of HF-QRS analysis compared with ST evaluation for substantial myocardial ischemia by exercise SPECT myocardial perfusion imaging (MPI). METHODS AND RESULTS: Exercise SPECT MPI was performed in 257 consecutive eligible patients (mean age 59 ± 12, 67% male). An ischemic HF-QRS pattern was defined as a ≥ 1 µV absolute reduction and a ≥ 50% relative reduction of the root-mean-square of the 150-250 Hz band signal in ≥ 3 leads. Left ventricular ischemia of ≥ 10% on SPECT MPI was the diagnostic standard for substantial myocardial ischemia. HF-QRS analysis demonstrated incremental diagnostic value to ST evaluation plus clinical risk factors (AUC 0.804 vs 0.749, P < .0001). A HF-QRS + ST -analysis strategy identified 92.3% of subjects with substantial ischemia and no abnormality in 59.9% of the cohort. No cardiac events occurred in patients without substantial ischemia identified by HF-QRS analysis. CONCLUSIONS: In this prospective analysis, exercise stress ECG with HF-QRS analysis identified any and substantial ischemia with high diagnostic accuracy and may allow more than half of referred patients to safely avoid imaging.
Entities:
Keywords:
CAD; ETT; diagnostic and prognostic application
Authors: Daniel S Berman; Xingping Kang; Piotr J Slomka; James Gerlach; Ling de Yang; Sean W Hayes; John D Friedman; Louise E J Thomson; Guido Germano Journal: J Nucl Cardiol Date: 2007-07 Impact factor: 5.952
Authors: Edgar Argulian; Jose Ricardo F Po; Seth Uretsky; Kiran K Kommaraju; Suketukumar Patel; Vikram Agarwal; Randy Cohen; Alan Rozanski Journal: J Nucl Cardiol Date: 2016-02-24 Impact factor: 5.952
Authors: R Gianrossi; R Detrano; D Mulvihill; K Lehmann; P Dubach; A Colombo; D McArthur; V Froelicher Journal: Circulation Date: 1989-07 Impact factor: 29.690
Authors: Alan Rozanski; Heidi Gransar; Sean W Hayes; James Min; John D Friedman; Louise E J Thomson; Daniel S Berman Journal: J Am Coll Cardiol Date: 2013-03-12 Impact factor: 24.094
Authors: Eran Toledo; Jonathan A Lipton; Stafford G Warren; Shimon Abboud; Mike Broce; Donald R Lilly; Charles Maynard; B Daniel Lucas; Galen S Wagner Journal: J Electrocardiol Date: 2009-02-28 Impact factor: 1.438